YILDIRIM, Sedat et al. Impact of Blood Type on Treatment Response and Survival in HER2-Negative Metastatic Gastric Cancer. Cerrahpaşa Medical Journal, [S. l.], v. 49, n. 1, p. 1–6, 2025. DOI: 10.5152/cjm.2025.25042. Disponível em: https://cerrahpasamedj.org/index.php/pub/article/view/966. Acesso em: 17 dec. 2025.